Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Paravertebral Catheter Analgesia Versus Epidural Analgesia for Totally Minimally Invasive Esophagectomy

Official title: PAravertebral CaTheter Versus Epidural Analgesia in Totally Minimally Invasive Esophagectomies: a Randomized Controlled Trial

Run by University Hospital, Lille · NCT07434739 · Data updated 2026-11-12

This trial tests whether paravertebral catheter analgesia can provide comparable pain control to epidural analgesia for patients undergoing totally minimally invasive esophagectomy.

More Esophageal Cancer trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment506 (estimated)
SponsorUniversity Hospital, Lille
Academic / other
Locations1 site (Lille)
StatusRecruiting
StartedJune 22, 2026
Main results expectedJune 22, 2028
Study endsNovember 22, 2028
Registry record updatedSeptember 14, 2026
Trial IDNCT07434739 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with resectable esophageal cancer planned for totally minimally invasive esophagectomy (Ivor-Lewis type) with laparoscopic abdominal and thoracoscopic thoracic approaches.

Probably not a fit

Patients who have contraindications to regional anesthesia or those not undergoing a totally minimally invasive approach may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study compares two pain-management approaches in adults undergoing totally minimally invasive esophagectomy for esophageal cancer. Participants are assigned to receive either paravertebral catheter analgesia or thoracic epidural analgesia as part of multimodal analgesia. The trial focuses on postoperative pain, recovery markers, and safety in a real-world surgical setting. It leverages robot-assisted or non-robot-assisted minimally invasive techniques and standard adjuvant care. Results could inform pain management choices to optimize recovery after esophagectomy.

Why it matters

Potential benefit: If successful, patients may experience effective pain control with potentially fewer opioid needs and faster recovery.

How similar studies have gone: Previous analgesia studies support regional techniques for thoracic surgery, but direct comparisons in this exact minimally invasive esophagectomy context are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient requiring totally minimally invasive surgical esophagectomy (robot-assisted or not) with 2 Ivor-Lewis type approaches: laparoscopy for the abdominal approach and thoracoscopy for the thoracic approach.
* Age ≥ 18 years old
* Patient who has given written consent to participate in the trial
* Socially insured patient
* Patient willing to comply with all study procedures and duration

Exclusion Criteria:

* \- Intervention planned by open esophagectomy (laparotomy and/or thoracotomy)
* 3-stage esophagectomy, McKeown type
* Obesity with body mass index ≥ 35 kg.m-2 (due to the foreseeable difficulties arising from this BMI).
* Pregnancy
* Haemostasis trouble
* ASA score \> 3
* Renal failure (eGFR \< 50 mL/min)
* Ongoing opioid use (\>3 months prior to the day of surgery)
* Contraindication to local anesthesia
* Local infection
* Inability to receive informed information
* Person deprived of the liberty
* Person benefiting from a system of legal protection (guardianship…)

Where it's running

  • CHU de Lille
    Lille, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.